Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc
 
 
Facebook
 
ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Personality does not distinguish people with Fibromyalgia but identifies subgroups of patients

Friday 20 September 2013

 

From ProHealth:

 

Comedy-DramaPersonality does not distinguish people with fibromyalgia but identifies subgroups of patients.

By Xavier Torres, Ph.D., et al. • ProHealth.com • September 17, 2013

Personality does not distinguish people with fibromyalgia but identifies subgroups of patients.

Abstract:

OBJECTIVES: The objectives were to compare the personality of fibromyalgia (FM) patients with other chronic painful and nonpainful disorders considering the confusion due to psychopathology and to assess the clustering of FM patients according to their personality profile.

METHODS: Differences in the NEO Five-Factor Inventory between FM, non-FM chronic pain and drug-resistant epileptic patients were assessed including the confounding effect of demographics and psychopathological status by multivariate regression analysis. Clustering of FM patients was assessed by two-step cluster analysis. Differences in clinical severity and psychosocial problems between subgroups and their outcome 6 months after multidisciplinary treatment were assessed.

RESULTS: The final sample comprised 874 patients.

  • Once the effect of confounding variables was considered, clinically nonsignificant differences in personality were observed between groups.

  • FM patients could, however, be grouped into two clusters.

  • Cluster 1 was characterized by higher neuroticism and lower extraversion and showed a worse pretreatment clinical state including more psychosocial problems.

  • In spite of having reached a wider general improvement at 6-month follow-up, Cluster 1 patients remained more anxious and depressed.

CONCLUSIONS: Identifying personality-based subgroups of FM might allow implementing specific preventive strategies. FM treatment might be optimized by increasing medication compliance, improving therapeutic alliance and testing different therapeutic options and treatment sequencing for each personality subgroup.

Source: General Hospital Psychiatry, September 12, 2013. By Xavier Torres, Ph.D., Eva Bailles, Ph.D., Manuel Valdes, M.D., Ph.D., Fernando Gutierrez, Ph.D., Josep-Maria Peri, Ph.D., Anna Arias, B.Sc. (O.T., P.T.), M.Sc. (E.), Emili Gomez, M.D., Antonio Collado, M.D., Ph.D. Institut Clínic de Neurociències, Hospital Clínic de Barcelona.

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page